Search research articles
Contact Us
Filters
Showing results (71-80 of 139) with videos related to
Page
of 14
Sort By:
Bioengineered
|
May 17, 2022
Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions
Wan-Rong Yi, Mei-Juan Tu, Ai-Xi Yu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine
Ai-Ming Yu, Jeffrey R Idle, Kristopher W Krausz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 2026
Design, expression, purification, and application of novel recombinant miR-491 molecules to define the biogenesis and function of miR-491-3p versus -5p in posttranscriptional regulation of UDP-glucuronosyltransferase 1A1
Yimei Wang, Mei-Juan Tu, Neelu Batra, et al.
Pharmacology, Biochemistry, and Behavior
|
June 1, 2011
Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice
J C Winter, D J Amorosi, Kenner C Rice, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 28, 2014
Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells
Mei-Mei Li, Wei-Peng Wang, Wen-Juan Wu, et al.
Oncotarget
|
June 21, 2016
MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis
Mei-Juan Tu, Yu-Zhuo Pan, Jing-Xin Qiu, et al.
Acta Pharmaceutica Sinica. B
|
January 13, 2022
Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis <i>in vivo</i>
Linglong Deng, Hannah Petrek, Mei-Juan Tu, et al.
Acta Pharmaceutica Sinica. B
|
September 1, 2023
Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis <i>in vivo</i>' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]
Linglong Deng, Hannah Petrek, Mei-Juan Tu, et al.
Acta Pharmaceutica Sinica. B
|
June 14, 2019
Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition <i>via</i> the regulation of target ADME gene expression
Xin Li, Ye Tian, Mei-Juan Tu, et al.
Plos One
|
January 1, 2019
A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma
Fernando Alegre, Amanda R Ormonde, Kellie M Snider, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 139) with videos related to
Sort By:
Page
of 14
Bioengineered
|
May 17, 2022
Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions
Wan-Rong Yi, Mei-Juan Tu, Ai-Xi Yu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine
Ai-Ming Yu, Jeffrey R Idle, Kristopher W Krausz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 2026
Design, expression, purification, and application of novel recombinant miR-491 molecules to define the biogenesis and function of miR-491-3p versus -5p in posttranscriptional regulation of UDP-glucuronosyltransferase 1A1
Yimei Wang, Mei-Juan Tu, Neelu Batra, et al.
Pharmacology, Biochemistry, and Behavior
|
June 1, 2011
Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice
J C Winter, D J Amorosi, Kenner C Rice, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 28, 2014
Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells
Mei-Mei Li, Wei-Peng Wang, Wen-Juan Wu, et al.
Oncotarget
|
June 21, 2016
MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis
Mei-Juan Tu, Yu-Zhuo Pan, Jing-Xin Qiu, et al.
Acta Pharmaceutica Sinica. B
|
January 13, 2022
Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis <i>in vivo</i>
Linglong Deng, Hannah Petrek, Mei-Juan Tu, et al.
Acta Pharmaceutica Sinica. B
|
September 1, 2023
Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis <i>in vivo</i>' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]
Linglong Deng, Hannah Petrek, Mei-Juan Tu, et al.
Acta Pharmaceutica Sinica. B
|
June 14, 2019
Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition <i>via</i> the regulation of target ADME gene expression
Xin Li, Ye Tian, Mei-Juan Tu, et al.
Plos One
|
January 1, 2019
A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma
Fernando Alegre, Amanda R Ormonde, Kellie M Snider, et al.
Page
of 14